The PBRM1 gene helps cells control which parts of DNA are read, which keeps growth and repair organized. When it does not work properly, cells may grow less predictably and the chance of certain cancers, especially clear cell kidney cancer, can rise. This gene plays an important role in helping damaged cells stay under control. Changes in the PBRM1 gene are most often discussed in kidney tumors, where they can help explain how a cancer developed and sometimes how it may behave.
What is a gene?
Genes are stretches of DNA that provide instructions your cells use to make molecules or regulate activities in the body. Some genes carry the code for proteins, which do much of the cell’s work. Others mainly guide when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and functions, and can influence how you respond to food, stress, or medications. More detail is available in LearnHub.
Overview
PBRM1Gene function
What if the gene works
The PBRM1 gene helps cells control which genes are turned on or off. It supports normal cell growth, DNA repair, and other routine cell functions.
Risk
What if the gene does not work
Variants in the PBRM1 gene can cause a rare developmental condition with delayed development and intellectual disability, and can raise kidney cancer risk. Mild and severe variants may affect which features appear, when they start, and how marked they are.
Treatment
What does that mean for your treatment
For a pathogenic or loss-of-function variant in the PBRM1 gene, no PBRM1-specific treatment or management approach is currently established. In kidney cancer, the PBRM1 gene is being studied as a biomarker that may help predict response to immune checkpoint inhibitors and some targeted drugs, but it is not yet used routinely to guide drug choice.
Conditions associated with PBRM1
Gene function
What if the gene works
Your cells need the PBRM1 gene to read the right DNA instructions at the right time. It helps manage how tightly DNA is packed, which affects which genes are available for use. This is part of how the PBRM1 gene helps control cell growth and everyday cell maintenance.
The PBRM1 gene helps shift how DNA is packed so cells can reach the right instructions. This lets a cell use genes it needs for its current job while keeping others quieter.
Its protein works as part of a larger cell team that turns sets of genes up or down. This helps keep growth, energy use, and other routine activities well coordinated.
This gene helps cells respond to everyday DNA damage from normal wear and tear. It supports repair steps and gives the cell time to deal with the problem in an orderly way.
The PBRM1 gene also helps coordinate the timing of cell division. By guiding when cells prepare, pause, and move forward, it supports steady, controlled growth.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal differences between people, such as appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant changes how a gene works more substantially and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PBRM1 gene often reduce how well the cell can manage DNA packaging and gene control. In discussions of how PBRM1 gene variants affect cells, milder changes may partly weaken the protein’s shape, stability, or ability to join its protein team, while more severe variants can stop the full protein from being made at all. This loss of function can have a larger cellular impact, and in some cases it is linked to earlier or more pronounced PBRM1-related cancer features.
How variants are linked to conditions
Pathogenic variants in the PBRM1 gene are clearly linked to kidney cancer, especially clear cell renal cell carcinoma. Inherited pathogenic variants can cause a hereditary tendency to this cancer, while many PBRM1 changes found on tumor testing are acquired in the tumor itself. In studies of how PBRM1 variants are linked to clear cell renal cell carcinoma, this is the strongest and most consistent association. Carrying an inherited PBRM1 variant raises risk, but it does not mean cancer is certain.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely seen in the general population. Most do not have a direct effect on health and instead represent natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when multiple genes and environmental factors both contribute. In some situations, though, a single well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks linked to the PBRM1 gene. Risk can vary depending on the exact gene change, family history, and other personal factors. Anyone concerned about their own risk should speak with a doctor or genetic counselor.
Inheritance of PBRM1 variants
There is not yet a broadly confirmed single inheritance pattern for PBRM1-related health findings, because the clinical role of inherited changes in this gene is still being clarified. In practice, discussions about how variants of the PBRM1 gene are inherited are usually individualized to the person, the family history, and the specific variant. The PBRM1 gene is located on chromosome 3, which is an autosome, so you inherit one copy from your mother and one copy from your father.
What does my PBRM1 result mean for my family?
If your PBRM1 result is a disease-causing variant linked to a recognized inherited condition, close relatives such as parents, brothers, sisters, and children may also carry it. PBRM1-related conditions that are inherited are usually passed down in a dominant way, so one changed copy can run through a family. Some PBRM1-related developmental cases happen as a new change in one person, so a parent does not always have the same variant.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the PBRM1 gene, genetic testing reads the DNA from a blood or saliva sample. PBRM1 genetic testing can identify a variant that may help explain a kidney tumor or show whether a variant runs in a family. Results are reviewed in a lab and classified by how likely the variant is to affect health.
When should I consider getting a genetic test?
There is not yet a broadly established PBRM1-specific reason for genetic testing for most people. Testing may be discussed with a doctor or genetic counselor if you or several relatives have had kidney cancer, especially at a young age, or if a tumor test finds a PBRM1 change.
A genetic result is only one part of your health story
Genetic test results can offer useful insight, but how much they reveal depends on the condition and the specific type of variant. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put personal experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment may work well for one person, seem less effective for another, or cause more side effects in someone else. Small differences in how the body absorbs, breaks down, transports, or responds to a drug are common, and these differences can influence both benefit and sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape a person’s response to medications. It studies the links between genes and drugs to better explain why the same treatment can work differently from one person to another. For many medicines, genes affect both how strongly a drug works and how the body handles it. This information can support more informed and more individualized treatment decisions. To explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the PBRM1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about medicines or side effects are best discussed with your doctor. In cancer care, PBRM1 changes have been studied as a possible clue to how some kidney cancers respond to immune-based treatment, but this is not a routine guide for treatment decisions.
History
PBRM1 entered cancer genetics in 2011, when large sequencing studies of clear cell kidney cancer identified it as a frequently altered gene. Initially understood only through visible traits, later recognized as tied to a specific gene, this finding helped explain why some kidney tumors behave differently from others. From these first observations, research expanded steadily, and PBRM1 became part of a broader shift toward mapping the genetic changes inside tumors. Its discovery mattered because it showed that kidney cancer was shaped by more than the better known VHL pathway alone. In recent years, PBRM1 has also drawn attention in studies exploring why some cancers respond differently to immunotherapy, which has kept the gene in active clinical research.